Blueshift Asset Management’s Chemours CC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-19,397
Closed -$509K 339
2024
Q1
$509K Buy
+19,397
New +$553K 0.26% 119
2022
Q2
Sell
-16,440
Closed -$518K 715
2022
Q1
$518K Buy
+16,440
New +$514K 0.05% 432
2021
Q4
Sell
-12,394
Closed -$360K 885
2021
Q3
$360K Buy
12,394
+3,344
+37% +$108K 0.02% 747
2021
Q2
$315K Buy
+9,050
New +$300K 0.02% 712
2020
Q1
Sell
-13,756
Closed -$249K 259
2019
Q4
$249K Buy
+13,756
New +$228K 0.03% 659
2019
Q3
Sell
-43,309
Closed -$1.04M 743
2019
Q2
$1.04M Buy
43,309
+28,217
+187% +$832K 0.14% 244
2019
Q1
$561K Buy
+15,092
New +$549K 0.08% 369

Other funds holding CC

Blueshift Asset Management's CC Position: Q2 2024 in Review

Blueshift Asset Management sold out of Chemours (CC) in Q2 2024, closing a stake of 19,397 shares — an estimated $509K sold.

Blueshift Asset Management first reported a position in CC in Q1 2019 and held it in 7 quarters. The position peaked at $1.04M in Q2 2019. 435 funds tracked by Wall St. Rank hold CC as of Q2 2024.

  • Blueshift Asset Management reported no remaining Chemours position as of Q2 2024 after selling out during the quarter.
  • Blueshift Asset Management sold 19,397 Chemours shares in Q2 2024, an estimated $509K.
  • Blueshift Asset Management first reported a position in Chemours in Q1 2019 and held it in 7 quarters.
  • Blueshift Asset Management's Chemours position peaked at $1.04M in Q2 2019.
  • 435 funds tracked by Wall St. Rank held Chemours as of Q2 2024.

Based on Blueshift Asset Management's 13F filing for Q2 2024, filed 14 Aug 2024.